Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Raymond Lab, |
RCV000721123 | SCV000852011 | pathogenic | SYT1-associated neurodevelopmental disorder | 2018-07-01 | criteria provided, single submitter | research | |
SIB Swiss Institute of Bioinformatics | RCV000735272 | SCV000994932 | likely pathogenic | Infantile hypotonia-oculomotor anomalies-hyperkinetic movements-developmental delay syndrome | 2019-02-18 | criteria provided, single submitter | curation | This variant is interpreted as a Likely pathogenic for Baker-Gordon syndrome, autosomal dominant. The following ACMG Tag(s) were applied: PM2: Absent from controls (or at extremely low frequency if recessive) in Exome Sequencing Project, 1000 Genomes Project, or Exome Aggregation Consortium. PM6: Assumed de novo, but without confirmation of paternity and maternity. PS3-Moderate: Well-established functional studies show a deleterious effect (downgraded to Moderate). PM1: Located in a mutational hot spot and/or critical and well-established functional domain (e.g., active site of an enzyme) without benign variation. PP3: Multiple lines of computational evidence support a deleterious effect on the gene or gene product. |
OMIM | RCV000735272 | SCV000863520 | pathogenic | Infantile hypotonia-oculomotor anomalies-hyperkinetic movements-developmental delay syndrome | 2018-12-12 | no assertion criteria provided | literature only |